Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA)
Abstract
Introduction. Heart failure and type 2 diabetes mellitus are critical public health issues.
Objective. To characterize the risk factors for mortality in patients with heart failure and type 2 diabetes mellitus from a large registry in Colombia and to evaluate the potential effect modifications by type 2 diabetes mellitus over other risk factors.
Materials and methods. Heart failure patients with and without type 2 diabetes mellitus enrolled in the Registro Colombiano de Falla Cardíaca (RECOLFACA) were included. RECOLFACA enrolled adult patients with heart failure diagnosis from 60 medical centers in Colombia during 2017-2019. The primary outcome was all-cause mortality. Survival analysis was performed using adjusted Cox proportional hazard models.
Results. A total of 2514 patients were included, and the prevalence of type 2 diabetes mellitus was 24.7% (n = 620). We found seven independent predictors of short-term mortality for the general cohort, chronic obstructive pulmonary disease, sinus rhythm, triple therapy, nitrates use, statins use, anemia, and hyperkalemia. In the type 2 diabetes mellitus group, only the left ventricle diastolic diameter was an independent mortality predictor (HR = 0.96; 95% CI: 0.93-0.98). There was no evidence of effect modification by type 2 diabetes mellitus on the relationship between any independent predictors and all-cause mortality. However, a significant effect modification by type 2 diabetes mellitus between smoking and mortality was observed.
Conclusions. Patients with type 2 diabetes mellitus had higher mortality risk. Our results also suggest that type 2 diabetes mellitus diagnosis does not modify the effect of the independent risk factors for mortality in heart failure evaluated. However, type 2 diabetes mellitus significantly modify the risk relation between mortality and smoking in patients with heart failure.
Downloads
References
Tousoulis D, Oikonomou E, Siasos G, Stefanadis C. Diabetes mellitus and heart failure. Eur Cardiol. 2014;9:37-42. https://doi.org/10.15420/ecr.2014.9.1.37
Ciapponi A, Alcaraz A, Calderón M, Matta MG, Chaparro M, Soto N, et al. Burden of heart failure in Latin America: A systematic review and meta-analysis. Rev Esp Cardiol. 2016;69:1051-60. https://doi.org/10.1016/j.rec.2016.04.054
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation. 2020;141:e139-596. https://doi.org/10.1161/CIR.0000000000000757
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107-11. https://doi.org/10.2991/jegh.k.191028.001
Rosano GM, Vitale C, Seferovic P. Heart failure in patients with diabetes mellitus. Card Fail Rev. 2017;3:52-5. https://doi.org/10.15420/cfr.2016:20:2
Kasznicki J, Drzewoski J. Heart failure in the diabetic population – pathophysiology, diagnosis and management. Arch Med Sci. 2014;10:546-56. https://doi.org/10.5114/aoms.2014.43748
Qazi MU, Malik S. Diabetes and cardiovascular disease: Original insights from the Framingham Heart Study. Glob Heart. 2013;8:43-8. https://doi.org/10.1016/j.gheart.2012.12.008
Ziaeian B, Hernández AF, DeVore AD, Wu J, Xu H, Heidenreich PA, et al. Long-term outcomes for heart failure patients with and without diabetes: From the Get with the Guidelines-Heart Failure Registry. Am Heart J. 2019;211:1-10. https://doi.org/10.1016/j.ahj.2019.01.006
Win TT, Davis HT, Laskey WK. Mortality among patients hospitalized with heart failure and diabetes mellitus: Results from the National Inpatient Sample 2000-2010. Circ Heart Fail. 2016;9:e003023. https://doi.org/10.1161/CIRCHEARTFAILURE.115.003023
Selvarajah S, Uiterwaal CSPM, Haniff J, van der Graaf Y, Visseren FLJ, Bots ML, et al. Renal impairment and all-cause mortality in cardiovascular disease: Effect modification by type 2 diabetes mellitus. Eur J Clin Invest. 2013;43:198-207. https://doi.org/10.1111/eci.12035
Bauters C, Lamblin N, Mc Fadden EP, van Belle E, Millaire A, de Groote P. Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol. 2003;2:1. https://doi.org/10.1186/1475-2840-2-1
Gómez-Mesa JE, Saldarriaga-Giraldo CI, Echeverría LE, Luna-Bonilla P, Grupo Investigador RECOLFACA. Registro Colombiano de Falla Cardíaca (RECOLFACA): resultados. Rev Colomb Cardiol. 2021;28:334-42.
Gómez-Mesa JE, Saldarriaga CI, Echeverría LE, Luna P, RECOLFACA research group. Colombian heart failure registry (RECOLFACA): Methodology and preliminary data. Rev Colomb Cardiol. 2021;28:217-30.
Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-6. https://doi.org/10.1001/jama.286.4.421
Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, et al. The independent and combined risk of diabetes and non-endstage renal impairment in non-STsegment elevation acute coronary syndromes. Int J Cardiol. 2008;131:105-12. https://doi.org/10.1016/j.ijcard.2007.09.006
Dauriz M, Mantovani A, Bonapace S, Verlato G, Zoppini G, Bonora E, et al. Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: A metaanalysis. Diabetes Care. 2017;40:1597-605. https://doi.org/10.2337/dc17-0697
Gómez-Mesa JE, Gutiérrez-Posso JM, Escalante-Forero M, Córdoba-Melo BD, Cárdenas-Marín PA, Perna ER, et al. American registry of ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients. Clin Cardiol. 2024;47:e24182. https://doi.org/10.1002/clc.24182
Jeong SM, Yoo JE, Park J, Jung W, Lee KN, Han K, et al. Smoking behavior change and risk of cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2023;22:193. https://doi.org/10.1186/s12933-023-01930-4
Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11:130-9. https://doi.org/10.1093/eurjhf/hfn013
Staszewsky L, Wong M, Masson S, Barlera S, Carretta E, Maggioni AP, et al. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: Data from the Val-HeFT heart failure trial. J Card Fail. 2007;13:797-804. https://doi.org/10.1016/j.cardfail.2007.07.012
Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Clinical Quality Improvement Network Investigators. Arch Intern Med. 1996;156:1669-73.
Gupta K, Kalra R, Rajapreyar I, Joly JM, Pate M, Cribbs MG, Ather S, et al. Anemia, mortality, and hospitalizations in heart failure with a preserved ejection fraction (from the TOPCAT Trial). Am J Cardiol. 2020;125:1347-54. https://doi.org/10.1016/j.amjcard.2020.01.046
Köseoğlu FD, Özlek B. Anemia and iron deficiency predict all-cause mortality in patients with heart failure and preserved ejection fraction: 6-year follow-up study. Diagnostics (Basel). 2024;14:209. https://doi.org/10.3390/diagnostics14020209
Brueske B, Sidhu MS, Schulman-Marcus J, Kashani KB, Barsness GW, Jentzer JC. Hiperkalemia is associated with increased mortality among unselected cardiac intensive care unit patients. J Am Heart Assoc. 2019;8:e011814. https://doi.org/10.1161/JAHA.118.011814
Girerd N, Zannad F, Rossignol P. Review of heart failure treatment in type 2 diabetes patients: It’s at least as effective as in non-diabetic patients! Diabetes Metab. 2015;41:446-55. https://doi.org/10.1016/j.diabet.2015.06.004
Kroon MH, van den Hurk K, Alssema M, Kamp O, Stehouwer CDA, Henry RMA, et al. Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: An 8-year follow-up of the Hoorn Study. Diabetes Care. 2012;35:2510-4. https://doi.org/10.2337/dc11-1959
Ebong IA, Goff DC, Rodríguez CJ, Chen H, Sibley CT, Bertoni AG. Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis. Circ Heart Fail. 2013;6:371-8. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000093
Cho MH, Lee K, Park SM, Chang J, Choi S, Kim K, et al. Effects of smoking habit change on all-cause mortality and cardiovascular diseases among patients with newly diagnosed diabetes in Korea. Sci Rep. 2018;8:5316. https://doi.org/10.1038/s41598-018-23729-0
Suárez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol. 1984;120:670-5. https://doi.org/10.1093/oxfordjournals.aje.a113933
Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, et al. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab. 2001;14:337-42.
Chen J, Marciniak TA, Radford MJ, Wang Y, Krumholz HM. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: Results from the national cooperative cardiovascular project. J Am Coll Cardiol. 1999;34:1388-94. https://doi.org/10.1016/s0735-1097(99)00383-6
Haas SJ, Vos T, Gilbert RE, Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J. 2003;146:848-53. https://doi.org/10.1016/S0002-8703(03)00403-4
Shekelle PG, Rich MW, Morton SC, Atkinson ColSW, Tu W, Maglione M, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A metaanalysis of major clinical trials. J Am Coll Cardiol. 2003;41:1529-38. https://doi.org/10.1016/s0735-1097(03)00262-6
MacDonald MR, Petrie MC, Varyani F, Östergren J, Michelson EL, Young JB, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:1377-85. https://doi.org/10.1093/eurheartj/ehn153
Erland E, Philippe L, Patricia V, Hermann W. Results from post-hoc analyses of the CIBIS II trial: Effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail. 2001;3:469-79. https://doi.org/10.1016/S1388-9842(01)00174-X
Rickli H, Steiner S, Müller K, Hess OM. Betablockers in heart failure: Carvedilol Safety Assessment (CASA 2-trial). Eur J Heart Fail. 2004;6:761-8. https://doi.org/10.1016/j.ejheart.2003.11.025
Doughty RN, Wright SP, Pearl A, Walsh HJ, Muncaster S, Whalley GA, et al. Randomized, controlled trial of integrated heart failure management. The Auckland Heart Failure Management Study. Eur Heart J. 2002;23:139-46. https://doi.org/10.1053/euhj.2001.2712
Driscoll A, Srivastava P, Toia D, Gibcus J, Hare DL. A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy--a randomized controlled trial. BMC Res Notes. 2014;7:668. https://doi.org/10.1186/1756-0500-7-668
Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11:130-9. https://doi.org/10.1093/eurjhf/hfn013
De Blois J, Simard S, Atar D, Agewall S, Norwegian Heart Failure Registry. COPD predicts mortality in HF: The Norwegian Heart Failure Registry. J Card Fail. 2010;16:225-9. https://doi.org/10.1016/j.cardfail.2009.12.002
Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818-27. https://doi.org/10.1016/j.jacc.2008.04.061
Chairat K, Rattanavipanon W, Tanyasaensook K, Chindavijak B, Chulavatnatol S, Nathisuwan S. Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand. Int J Cardiol Heart Vasc. 2020;30:100597. https://doi.org/10.1016/j.ijcha.2020.100597
Pan A, Wang Y, Talaei M, Hu FB. Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: A meta-analysis and systematic review. Circulation. 2015;132:1795-804. https://doi.org/10.1161/CIRCULATIONAHA.115.017926
Campagna D, Alamo A, Di Pino A, Russo C, Calogero AE, Purrello F, et al. Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019;11:85. https://doi.org/10.1186/s13098-019-0482-2
Some similar items:
- Guillermo Edinson Guzmán, Veline Martínez, Sebastián Romero, María Mercedes Cardozo, María Angélica Guerra, Oriana Arias, Combined hyperglycemic crises in adult patients already exist in Latin America. , Biomedica: Vol. 44 No. Sp. 1 (2024): Enfermedades crónicas no transmisibles
- Karen Feriz, Maria B. Iriarte, Oscar Giraldo, Luis G. Parra -Lara, Veline Martinez, Maria A. Urbano, Guillermo Guzman, Clinical outcomes in patients with diabetes and stress hyperglycemia that developed SARS-CoV-2 infection , Biomedica: Vol. 44 No. Sp. 1 (2024): Enfermedades crónicas no transmisibles
- Julio César Velasco, Ledmar Jovanny Vargas , Lorena García, Iván José Torres, Iván Camilo González , Oral mucormycosis associated with COVID-19 and diabetes mellitus: Case report and literature review , Biomedica: Vol. 44 No. 1 (2024)
- Eduardo Tuta-Quintero, Alirio R. Bastidas, Luis F. Giraldo-Cadavid, Juliana Echeverri, Juan D. Botero, Valentina Villarreal, Camila Zambrano, Valeria Rabe, Juan Hernández, Daniel Tavera, Juan Acosta, Ángela Martínez, Carlos Granados, María Nieto, Sergio E. Román, William A. Achry , Jonathan Guezguan-Pérez, Paula Prieto, Diana Parra-Cárdenas, Factors related to mortality in patients with chronic obstructive pulmonary disease in Colombian population , Biomedica: Vol. 44 No. Sp. 1 (2024): Enfermedades crónicas no transmisibles
- Liliana Villa, Iván Mauricio Trompa, Fernando Nicolás Montes, Joaquín Guillermo Gómez, Carlos Andrés Restrepo, Analysis of mortality caused by tuberculosis in Medellín, Colombia, 2012 , Biomedica: Vol. 34 No. 3 (2014)
- Álvaro J. Ruiz, Pablo J. Aschner, María Fernanda Puerta, Rafael Alfonso-Cristancho, IDEA Study (International Day for the Evaluation of Abdominal Obesity): Primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia , Biomedica: Vol. 32 No. 4 (2012)
- Ligia Inés Moncada, Sandra Milena Rios, Julián Alfredo Fernández, Fabio Rivas, María Luz Sáenz, Pediculosis prevalence and associated risk factors in a nursery school, Bogotá, Colombia , Biomedica: Vol. 28 No. 2 (2008)
- Karen Melissa Ordóñez, Odismar Andrea Hernández, Jorge Alberto Cortés, María José López, Gladys Alfonso, Alejandro Junca, Left-sided infective endocarditis caused by Pseudomonas aeruginosa treated medically , Biomedica: Vol. 30 No. 2 (2010)
- María del Pilar Chaves, Julián Alfredo Fernández, Isabel Ospina, Myriam Consuelo López, Ligia Moncada, Patricia Reyes, Giardia duodenalis prevalence and associated risk factors in preschool and school-age children of rural Colombia , Biomedica: Vol. 27 No. 3 (2007)
- Elpidia Poveda, Alexandra Cuartas, Saralicia Guarín, Yibby Forero, Elsa Villarreal, Iron and vitamin A micronutrient status, risk factors for their deficiencies and anthropometric assessment in preschool child from Funza municipality, Colombia , Biomedica: Vol. 27 No. 1 (2007)
Copyright (c) 2024 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
